Urol. praxi. 2019;20(3):116-118 | DOI: 10.36290/uro.2019.059

Estrogens and urinary incontinence in women

MUDr. Lukáš Horčička
GONA spol. s r.o., Urogynekologická ambulance

Urinary incontinence, an involuntary uncontrolled leakage of urine, affects up to 50% of women at some point during their lives. Women
around and after menopause are at the most risk. Gradual loss of ovarian function results in a decrease in estrogen level. Estrogen
deficiency causes atrophy in the tissues of the uropoietic system with all the consequences, including the development or deterioration
of urinary incontinence. Local estrogen replacement has been shown to have a positive effect on the quality of life of patients as well as
on symptom improvement, whether as monotherapy or in combination with other treatment options for incontinence.

Keywords: incontinence, menopause, estrogens, urogenital atrophy

Published: July 1, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horčička L. Estrogens and urinary incontinence in women. Urol. praxi. 2019;20(3):116-118. doi: 10.36290/uro.2019.059.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrams P, et al. Clinical Manual of Incontinence in Women. Health Publications 2005.
    2. Calleja-Agius J, Brincat M. Urogenital atrophy. Climacteric 2009; 12(4): 279-285. Go to original source... Go to PubMed...
    3. Abrams P, et al. Incontinence, 6th Edition 2017: 896-899.
    4. Cardozo L. Role of estrogens in the treatment of female urinary incontinence. JAGS 1990; 38: 326-328. Go to original source... Go to PubMed...
    5. Gärtner M. Hormonální terapie a léčba inkontinence moči. Praktická gynekologie 2006; 10(4): 147-148.
    6. Líbalová Z, et al. Doporučený postup vaginální estrogenní terapie. Čes. Gynek. 2008; 73: 62-63.
    7. Líbalová Z, et al. Vaginální estrogenní terapie. Moderní gynekologie a porodnictví 2007; 16(3, Suplementum): 579-598.
    8. Hejlová P, Zmrhal J. Vliv estrogenu na dolní cesty močové. Praktická gynekologie 2002; 4: 26-28.
    9. Horčička L, Chmel R. Využití lokálně aplikovaných estrogenů v léčbě urogenitálních potíží. Gynekolog 1997; 6: 73-74.
    10. Horčička L, et al. Inkontinence moči v každodenní praxi. 2. vydání 2017; 60: 65-66.
    11. Kolařík D. Konzervativní léčba v urogynekologii. In: Halaška, et al. Urogynekologie. Galén 2004: 75-87.
    12. Kolařík D, Martan A. Farmakologická léčba v urogynekologii. In: Halaška, et al. Urogynekologie. Galén 2004: 95-107.
    13. Krhut J. Farmakologická léčba stresové inkontinence. Urologie pro praxi 2006; 2: 52-54.
    14. Robinson D, Cardozo L. The role of estrogens in female lower urinary tract dysfunction. Urology 2003; 62: 45-51. Go to original source... Go to PubMed...
    15. Simunic V, et al. Local estrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obset 2003; 82: 187-197. Go to original source... Go to PubMed...
    16. Waetjen LE, et al. Factors associated with worsening and improving urinary incontinence across the postmenopausal transition. Obstet Gynecol 2008; 111(3): 667-677. Go to original source...
    17. Živný J, Fait T. Endokrinologie klimakteria a hormonální substituční terapie. Psychiatrie pro praxi 2003; 3: 101-106.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.